ATE450264T1 - Prostaglandin enthaltendes produkt - Google Patents

Prostaglandin enthaltendes produkt

Info

Publication number
ATE450264T1
ATE450264T1 AT04771296T AT04771296T ATE450264T1 AT E450264 T1 ATE450264 T1 AT E450264T1 AT 04771296 T AT04771296 T AT 04771296T AT 04771296 T AT04771296 T AT 04771296T AT E450264 T1 ATE450264 T1 AT E450264T1
Authority
AT
Austria
Prior art keywords
aqueous liquid
liquid preparation
prostaglandin
prostaglandin derivative
container
Prior art date
Application number
AT04771296T
Other languages
English (en)
Inventor
Akio Kimura
Hiroshi Yamada
Takehiro Kado
Masayuki Ikeda
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE450264T1 publication Critical patent/ATE450264T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D65/00Wrappers or flexible covers; Packaging materials of special type or form
    • B65D65/38Packaging materials of special type or form
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/02Polyesters derived from dicarboxylic acids and dihydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/02Polyesters derived from dicarboxylic acids and dihydroxy compounds
    • C08L67/03Polyesters derived from dicarboxylic acids and dihydroxy compounds the dicarboxylic acids and dihydroxy compounds having the carboxyl- and the hydroxy groups directly linked to aromatic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1397Single layer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Mechanical Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT04771296T 2003-07-31 2004-07-30 Prostaglandin enthaltendes produkt ATE450264T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003283840 2003-07-31
PCT/JP2004/011282 WO2005011704A1 (ja) 2003-07-31 2004-07-30 プロスタグランジン含有製品

Publications (1)

Publication Number Publication Date
ATE450264T1 true ATE450264T1 (de) 2009-12-15

Family

ID=34113821

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04771296T ATE450264T1 (de) 2003-07-31 2004-07-30 Prostaglandin enthaltendes produkt

Country Status (5)

Country Link
US (2) US20060199863A1 (de)
EP (1) EP1666043B1 (de)
AT (1) ATE450264T1 (de)
DE (1) DE602004024427D1 (de)
WO (1) WO2005011704A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
ES2588581T3 (es) * 2004-12-09 2016-11-03 Santen Pharmaceutical Co., Ltd. Producto que contiene prostaglandina con átomo de flúor en su molécula
DK1829545T3 (da) * 2004-12-24 2012-07-23 Santen Pharmaceutical Co Ltd Produkter indeholdende prostaglandin-F2alfa-derivat
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (de) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
EP2452669A1 (de) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmische Zusammensetzung
EP2567689A1 (de) 2011-09-12 2013-03-13 Visiotact Pharma Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure
WO2020013717A1 (en) 2018-07-09 2020-01-16 Warszawskie Zaklady Farmaceutyczne Polfa Sa Ophthalmic dispensing device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
JPS57131242A (en) * 1981-02-09 1982-08-14 Teijin Ltd Polyester container
JPH0632649B2 (ja) * 1986-02-20 1994-05-02 ロ−ト製薬株式会社 液状医薬品包装体
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
JPH0733650A (ja) * 1993-07-26 1995-02-03 Lion Corp ビタミンa類可溶化水性点眼剤
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
JP3480549B2 (ja) * 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
DE69922916T2 (de) * 1998-07-14 2005-06-09 Alcon Manufacturing Ltd., Fort Worth Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
CA2422031C (en) * 2000-09-13 2011-11-15 Santen Pharmaceutical Co., Ltd. Ophthalmic solutions comprising difluoroprostaglandin f2 alpha
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Also Published As

Publication number Publication date
US20060199863A1 (en) 2006-09-07
EP1666043A4 (de) 2008-02-27
EP1666043B1 (de) 2009-12-02
US20130178524A1 (en) 2013-07-11
WO2005011704A1 (ja) 2005-02-10
DE602004024427D1 (de) 2010-01-14
EP1666043A1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
da Rocha et al. Biodegradable films: An alternative food packaging
DE602004024427D1 (de) Prostaglandin enthaltendes produkt
SE0701087L (sv) Ny produkt
WO2007124237A3 (en) Systems and methods for providing a thermoplastic product that includes packaging therefor
SG155821A1 (en) Dispensing container device
AR078931A1 (es) Producto envasado para proteger composiciones liquidas sensibles a la luz
EP1789343A4 (de) Verbessertes spraydosenventil
ATE466494T1 (de) Verfahren zur entfernung von schwefelgeruch von verpackungen
MY174448A (en) Nutritive substance delivery container
AR046254A1 (es) Productos farmaceuticos estables
MX2007005658A (es) Producto en aerosol antitranspirante con empaque tratado contra corrosion.
SE0302455L (sv) Förpackning för förvaring av varor i ett preserverande tillstånd samt förfarande för förfärdigande av dylika förpackningar
MXPA04004733A (es) Composiciones liposomales secas de pvp-yodo.
ATE367973T1 (de) Behälter zum verpacken von flüssigkeiten, insbesondere getränken
FR2967894B1 (fr) Dispositif de conditionnement, de conservation et de preparation extemporanee d'un ou plusieurs principe(s) actif(s).
CN203229007U (zh) 防霉保鲜的包装材料结构
DE502005011092D1 (de) Pharmazeutische Schutzverpackung
DE602005027408D1 (de) Bei der verpackung von arzneimitteln und kosmetika verwendeter behälter
WO2005105602A3 (en) Container for packaging frozen or chilled food products
EP2807969A1 (de) Seifenverpackung
CN205574650U (zh) 一种方便撕膜的化妆品包装盒
CN201021377Y (zh) 包装瓶
JP2002191970A (ja) ホルムアルデヒド除去剤
JP1760823S (ja) 包装用容器
JP1760824S (ja) 包装用容器

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties